Strategic Partnerships
Optimising the Sponsor/Provider Performance; Genzyme Best Practice
July 22 by Pharmaceuticals & Biotechnology EditorIn this transcripts of Pharma IQ's interview with Larry Blankstein, we look at best practice approaches to secure alliances and strategic partnerships, no matter what size the bu...
Optimise the Sponsor/Provider Performance; Genzyme Best Practice
March 05 by Niamh MadiganThis podcast looks at best practice approaches to secure alliances and strategic partnerships, no matter what size the business is or where you are operating from when looking at clinical...
Global Insights on Pharmaceutical Contract Manufacturing
August 10 by Pharmaceuticals & Biotechnology EditorAgainst of backdrop of unsuccessful new drug discovery, patent expiry and a particularly tough global economic economy, the pharmaceutical industry model has had to change and over the last 10 years...
Unlocking the Value of Strategic Partnerships with CRO’s and Pharmaceutical Companies in Asia
March 02 by Frank FloetherIntroduction Considering potential benefits and the impact of pitfalls of any Asian offshoring ambitions you need to analyse your situation and intentions first to establish the right base to unl...
AstraZeneca: Discovering Drugs Through Partnerships
October 25 by Pharma IQDrug discovery projects are not cheap. The start of projects to consider new treatments for a range of diseases can be vast in their scope, meaning the development process can cost a significant amoun...
Drug Discovery Outsourcing: Strategy, Selection & Success
June 21 by Andrea CharlesRichard Morphy from the Medicinal Chemistry Dept at the Schering-Plough Research Institute, joins Pharma IQ to discuss tactical and strategic partnerships and etablishing efficient discove...